The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
- 31 October 1998
- Vol. 317 (7167) , 1185-1190
- https://doi.org/10.1136/bmj.317.7167.1185
Abstract
Objective To summarise comparisons of randomised clinical trials and non-randomised clinical trials, trials with adequately concealed random allocation versus inadequately concealed random allocation, and high quality trials versus low quality trials where the effect of randomisation could not be separated from the effects of other methodological manoeuvres. Design Systematic review. Selection criteria Cohorts or meta-analyses of clinical trials that included an empirical assessment of the relation between randomisation and estimates of effect. Data sources Cochrane Review Methodology Database, Medline,SciSearch, bibliographies, hand searching of journals, personal communication with methodologists, and the reference lists of relevant articles. Main outcome measures Relation between randomisation and estimates of effect. Results Eleven studies that compared randomised controlled trials with non-randomised controlled trials (eight for evaluations of the same intervention and three across different interventions), two studies that compared trials with adequately concealed random allocation and inadequately concealed random allocation, and five studies that assessed the relation between qualityscores and estimates of treatment effects, were identified. Failure to use random allocation and concealment of allocation were associated with relative increases in estimates of effects of 150% or more, relative decreases of up to 90%, inversion of the estimated effect and, in some cases, no difference. On average, failure to use randomisation or adequate concealment of allocation resulted in larger estimates of effect due to a poorer prognosis in non-randomly selected control groups compared with randomly selected control groups. Conclusions Failure to use adequately concealed random allocation can distort the apparent effects of care in either direction, causing the effects to seem either larger or smaller than they really are. The size of these distortions can be as large as or larger than the size of the effects that are to be detected.Keywords
This publication has 36 references indexed in Scilit:
- A review and meta-analysis of hormonal treatment of cryptorchidismJournal of Clinical Endocrinology & Metabolism, 1995
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working GroupJAMA, 1994
- Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working GroupJAMA, 1993
- Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: Observations on the role of trial design and implications of drug-related mortalityAmerican Heart Journal, 1992
- Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysisThe Lancet, 1992
- How study design affects outcomes in comparisons of therapy. II: SurgicalStatistics in Medicine, 1989
- How study design affects outcomes in comparisons of therapy. I: MedicalStatistics in Medicine, 1989
- Bias in Treatment Assignment in Controlled Clinical TrialsNew England Journal of Medicine, 1983
- Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial InfarctionNew England Journal of Medicine, 1977